Thermosensitive Pluronic® F127-Based in situ gel formulation containing nanoparticles for the sustained delivery of paclitaxel

Bone metastasis is one of the most encountered complications among cancer patients and majority of cancer types has led to bone metastasis. Paclitaxel (PCX) is an anticancer agent commonly used in cancer treatment. However, its clinical use is restricted owing to poor water solubility. PCL NPs were...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Sedat Unal, Merve Celik Tekeli, Osman Dogan, Yesim Aktas
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Society of Turaz Bilim 2023-03-01
Σειρά:	Medicine Science
Θέματα:	cancer nanoparticles paclitaxel in situ gel drug release
Διαθέσιμο Online:	https://www.medicinescience.org/?mno=132661
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!